Crestor still challenges Lipitor

Published: 2013-03-07 06:58:00

Updated: 2013-03-07 06:58:00

The growing patient population and the increasing demand for cholesterol reducing "statins," has successfully sustained the appeal of this maturing market over the past several years. The marketing excellence, and the much-needed aggression demonstrated by Lipitor has transformed the way hyperlip...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK